AP NEWS
ADVERTISEMENT
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

INVESTOR ALERT: Kirby McInerney LLP Announces an Investigation of Shareholder Claims Against Merit Medical Systems, Inc.

April 9, 2021 GMT

NEW YORK--(BUSINESS WIRE)--Apr 9, 2021--

The law firm of Kirby McInerney LLP is investigating claims against Merit Medical Systems, Inc. (“Merit Medical” or the “Company”) (NASDAQ: MMSI ). The investigation focuses on whether the Company’s board of directors has breached its fiduciary duties to the Company.

ADVERTISEMENT

If you purchased or otherwise acquired Merit Medical securities, have information, or would like to learn more about these claims, please contact Thomas W. Elrod of Kirby McInerney LLP at 212-371-6600, by email at investigations@kmllp.com, or by filling out this contact form, to discuss your rights or interests with respect to these matters without any cost to you.

Kirby McInerney LLP is a New York-based plaintiffs’ law firm concentrating in securities, antitrust, whistleblower, and consumer litigation. The firm’s efforts on behalf of shareholders in securities litigation have resulted in recoveries totaling billions of dollars. Additional information about the firm can be found at Kirby McInerney LLP’s website: http://www.kmllp.com.

ADVERTISEMENT

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

View source version on businesswire.com:https://www.businesswire.com/news/home/20210409005484/en/

CONTACT: Kirby McInerney LLP

Thomas W. Elrod, Esq.

212-371-6600

https://www.kmllp.com

investigations@kmllp.com

KEYWORD: UNITED STATES NORTH AMERICA NEW YORK

INDUSTRY KEYWORD: LEGAL PROFESSIONAL SERVICES

SOURCE: Kirby McInerney LLP

Copyright Business Wire 2021.

PUB: 04/09/2021 07:30 PM/DISC: 04/09/2021 07:30 PM

http://www.businesswire.com/news/home/20210409005484/en